Pneumococcal Vaccination for Patients with Newly Diagnosed Liver Metastases from Cancer
Adults newly diagnosed with cancer, including those with liver metastases, should receive pneumococcal conjugate vaccine PCV20 as a single dose if they are pneumococcal vaccine-naïve. 1
Primary Recommendation
For vaccine-naïve patients with newly diagnosed cancer (including metastatic disease):
- Administer PCV20 (preferred) - single dose, no additional PPSV23 needed 1
- Alternative approach: PCV15 followed by PPSV23 at least 8 weeks later 1
The 2024 NCCN guidelines explicitly state that PCV20 should be given to adults who are newly diagnosed with cancer who are pneumococcal vaccine-naïve, which directly applies to your patient with new liver metastases 1.
For Patients with Prior Pneumococcal Vaccination
The vaccination strategy depends on what they previously received:
If previously received PPSV23 only:
- Give PCV20 (preferred) or PCV15 now 1
If previously received PCV13 only:
- Give PCV20 at least 1 year after PCV13 (rather than PPSV23) 1
If previously received PCV13 + 1-2 doses of PPSV23:
- Give PCV20 at least 5 years after last PPSV23 1
Clinical Rationale
Pneumococcal vaccination reduces morbidity and mortality in cancer patients by:
A study in elderly lung cancer patients demonstrated that PPSV23 given during the anti-cancer treatment period (first 6 months post-diagnosis) reduced CAP hospitalizations by 26% (IRR = 0.74, P = 0.0339) and improved 2-year survival rates (46.6% vs 26.2%, P < 0.001) 3. While this study used PPSV23, it underscores the importance of early vaccination during cancer treatment.
Timing Considerations
Administer vaccination promptly after cancer diagnosis - there is no specified waiting period for solid tumor malignancies with metastases 1. The evidence suggests vaccinating during the anti-cancer treatment period is both safe and effective 3.
Important caveat: Avoid live vaccines during chemotherapy or significant immunosuppression, but pneumococcal vaccines are inactivated and safe to give 1.
Common Pitfalls to Avoid
- Don't delay vaccination waiting for "optimal timing" - early vaccination during cancer treatment is beneficial 3
- Don't give PPSV23 first in vaccine-naïve patients - conjugate vaccines (PCV20/PCV15) should be given before or instead of PPSV23 1
- Don't forget to check prior vaccination history through immunization registries - this determines the appropriate vaccine and timing 1
Additional Vaccination Priorities
While addressing pneumococcal vaccination, ensure this patient also receives:
- Annual influenza vaccine (inactivated or recombinant) 1
- COVID-19 vaccination (updated formulation) 1
- Recombinant zoster vaccine if ≥50 years old (2 doses, 2-6 months apart) 1
All household contacts should be up-to-date with vaccinations to protect the immunocompromised patient 1.